Globe Life (NYSE:GL) Updates FY 2025 Earnings Guidance

Key Points

• Globe Life has updated its FY 2025 earnings guidance to a range of 14.400-14.600 EPS, slightly above the consensus estimate of 14.410. It has also set its FY 2026 guidance at 14.600-15.300 EPS.
• Several brokerages have recently raised their price targets for Globe Life, with Truist Financial establishing a "buy" rating and a target price of $150.00, while Wells Fargo increased its target to $172.00.
• Globe Life's stock is currently trading at $135.52, reflecting a modest 0.4% decrease in trading, with a market cap of approximately $10.98 billion.

Globe Life (NYSE:GL - Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 14.400-14.600 for the period, compared to the consensus earnings per share estimate of 14.410. The company issued revenue guidance of -. Globe Life also updated its FY 2026 guidance to 14.600-15.300 EPS.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on GL. Truist Financial began coverage on Globe Life in a report on Tuesday, July 15th. They set a "buy" rating and a $150.00 price objective for the company. Keefe, Bruyette & Woods boosted their price objective on Globe Life from $145.00 to $155.00 and gave the stock an "outperform" rating in a report on Monday, July 28th. Morgan Stanley set a $179.00 price objective on Globe Life and gave the stock an "overweight" rating in a report on Tuesday, October 7th. BMO Capital Markets reaffirmed a "market perform" rating and issued a $149.00 target price (up previously from $114.00) on shares of Globe Life in a research note on Wednesday, July 30th. Finally, Wells Fargo & Company lifted their price target on shares of Globe Life from $150.00 to $172.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 8th. Eight research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $152.11.

Globe Life Trading Down 0.4%

Shares of Globe Life stock traded down $0.49 during trading on Wednesday, reaching $135.52. The company's stock had a trading volume of 681,848 shares, compared to its average volume of 631,337. The company has a market cap of $10.98 billion, a price-to-earnings ratio of 10.83 and a beta of 0.55. Globe Life has a 52-week low of $100.27 and a 52-week high of $147.83. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.43. The firm's 50-day moving average is $139.70 and its two-hundred day moving average is $129.13.

Globe Life (NYSE:GL - Get Free Report) last released its quarterly earnings data on Wednesday, October 22nd. The company reported $4.81 earnings per share for the quarter, beating analysts' consensus estimates of $4.52 by $0.29. Globe Life had a return on equity of 21.24% and a net margin of 18.11%. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS. FY 2025 guidance at 14.400-14.600 EPS. On average, sell-side analysts anticipate that Globe Life will post 13.87 earnings per share for the current year.

Globe Life Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, October 3rd will be issued a $0.27 dividend. The ex-dividend date is Friday, October 3rd. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. Globe Life's dividend payout ratio is 8.63%.

Insider Transactions at Globe Life

In other news, CEO Frank M. Svoboda sold 12,500 shares of the firm's stock in a transaction on Thursday, July 31st. The stock was sold at an average price of $141.38, for a total transaction of $1,767,250.00. Following the completion of the transaction, the chief executive officer directly owned 32,747 shares in the company, valued at $4,629,770.86. This trade represents a 27.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael Clay Majors sold 10,000 shares of the firm's stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $137.41, for a total value of $1,374,100.00. Following the completion of the transaction, the executive vice president directly owned 47,066 shares in the company, valued at $6,467,339.06. The trade was a 17.52% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 84,722 shares of company stock worth $11,733,793 in the last ninety days. 1.51% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. AQR Capital Management LLC raised its stake in shares of Globe Life by 98.6% in the second quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company's stock worth $174,340,000 after buying an additional 696,548 shares during the period. Ameriprise Financial Inc. raised its stake in shares of Globe Life by 3.6% in the second quarter. Ameriprise Financial Inc. now owns 760,105 shares of the company's stock worth $94,473,000 after buying an additional 26,765 shares during the period. Bank of America Corp DE raised its stake in shares of Globe Life by 8.3% in the second quarter. Bank of America Corp DE now owns 655,842 shares of the company's stock worth $81,515,000 after buying an additional 50,344 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of Globe Life by 11.5% in the first quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company's stock worth $74,161,000 after buying an additional 58,163 shares during the period. Finally, Raymond James Financial Inc. raised its stake in shares of Globe Life by 3.5% in the second quarter. Raymond James Financial Inc. now owns 560,697 shares of the company's stock worth $69,689,000 after buying an additional 19,150 shares during the period. Institutional investors own 81.61% of the company's stock.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.